FemTech software development
Navigating the transition from wellness applications to regulated medical products requires a partner that integrates compliance into the engineering lifecycle. Revolve Healthcare provides the technical depth and regulatory oversight necessary to secure MDR and FDA approvals without late-stage redesigns.

Why Revolve Healthcare delivers regulatory-first excellence
50+ Engineering & Regulatory Experts
4.9/5 Client Satisfaction Rating
ISO 13485 Certified Quality Management
MDR/FDA Compliance-Ready Delivery

What makes the Best Software Company for FemTech?
The FemTech market is projected to reach $19 billion by 2031, with a 14-16% CAGR. As products move from consumer wellness to clinical diagnostics, the definition of a "best" partner shifts from UX speed to regulatory durability. This transition often involves processing more sensitive health data, increasing both regulatory expectations and the potential impact of security failures. According to ASPR, healthcare data breaches cost an average of $10.93 million per incident, making security-by-design a non-negotiable criterion.
Clinical-Grade Security
MDR & FDA Alignment
IEC 62304 Compliance
Usability Engineering
Why Revolve Healthcare Leads in MedTech Execution
Revolve Healthcare operates as a technology partner rather than a generic agency. We lead the software, compliance, and delivery workstreams together to reduce the execution burden on your team. Sustainable growth in MedTech is driven by specialised expertise rather than commodity services.
Regulatory-First Delivery. We develop software and documentation in parallel. This often results in a 30% reduction in time-to-market for regulated products by avoiding post-hoc documentation cycles.
In-House Regulatory Team. Our engineering team works alongside an in-house regulatory department. This creates a feedback loop where compliance requirements inform technical architecture in real-time.
Operational Ownership. We take operational ownership of the development lifecycle. However, we maintain transparent decision-making so you never lose strategic control over your FemTech product.

Awards and Recognition for Medical Software Excellence
Trust in MedTech is built on verified performance. Revolve Healthcare has been recognised for its continued expansion within the highly regulated healthcare sector. Our growth is built on medical device software expertise and long-term partnerships with healthcare organisations seeking specialised support.
Revolve Healthcare has been listed in the FT1000: Europe’s Fastest-Growing Companies 2026. This ranking recognises organisations that have achieved outstanding revenue growth across Europe through independently verified financial data.

How to Choose the Right FemTech Development Partner
Selecting a partner for a regulated product is a risk-management decision. Follow these five steps to ensure your software meets clinical and regulatory standards.
Verify ISO 13485 Certification
Assess Regulatory Technical Depth
Evaluate FemTech Experience
Check for Parallel Documentation
Review Decision-Making Transparency
Why FemTech leaders choose Revolve Healthcare
Revolve Healthcare is recognised as a fastest-growing medical device software company in Europe. Our inclusion in the FT1000 2026 confirms our operational maturity and ability to scale while maintaining strict healthcare standards. For FemTech companies moving from wellness to medical-grade products, we offer a path to audit-readiness that minimizes risk and maximizes clinical impact.

Supporting local FemTech initiatives
We actively support local initiatives connected with women’s health and digital healthcare innovation. Revolve Healthcare is also a partner of “FemTech po Polsku” (eng. FemTech in Polish/FemTech, Polish-style), supporting the growth of secure, scalable, and compliance-ready healthcare products within the Polish FemTech ecosystem.

Let's Talk
Agata Neale-Orzechowska
Polish FemTech Community Leader
0048 792 018 663
agata@revolve.healthcare
